Eu Kiang Sharon Yeo

Nanyang Technological University

Papers

1

Total Citations

67

H-Index

1

About

Dr. Eu Kiang Sharon Yeo is a distinguished urologic oncologist whose research centers on the optimal management of upper tract urothelial carcinoma (UTUC), a relatively uncommon but aggressive malignancy. Her most cited work, a 2020 perspective piece with 67 citations, critically examines the stagnation in survival outcomes for UTUC over recent decades, advocating for a paradigm shift toward multi-modality treatment strategies. Dr. Yeo’s contributions are pivotal in bridging the gap between surgical and systemic therapies, emphasizing the need for personalized, integrated care to improve patient prognosis. Her research has significantly influenced clinical guidelines, highlighting the limitations of single-modality approaches and the promise of combined treatments. Beyond her seminal review, Dr. Yeo has advanced the understanding of risk stratification and therapeutic sequencing in UTUC, earning recognition as a leading voice in urologic oncology. Her work continues to shape how clinicians approach this challenging disease, offering new hope for better outcomes through evidence-based, collaborative care.

Research Focus

Key Achievements

1
H-Index
1
Papers
67
Total Citations
67
Avg Citations/Paper
🏆 Most Cited Paper
<p>Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives</p>
67 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Nanyang Technological University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago